The most common trade name for zolpidem is Ambien [1]. Other trade names for zolpidem include Ambien CR, Edluar, and Intermezzo [1][2].
What is Zolpidem Used For?
Zolpidem is a sedative-hypnotic medication prescribed to treat insomnia, specifically the difficulty falling asleep [3]. It works by slowing down activity in the brain, which can help a person fall asleep [3].
When Does the Patent for Ambien Expire?
The original patents for Ambien have long since expired, leading to the availability of generic versions [4]. This patent expiry is a common trend for widely used medications, allowing for more affordable alternatives to become available in the market.
How Does Zolpidem Compare to Other Sleep Medications?
Zolpidem is a non-benzodiazepine hypnotic, belonging to a class of drugs often referred to as "Z-drugs" [3][5]. Other Z-drugs include zaleplon and eszopiclone [5]. While they share a similar mechanism of action—enhancing the effect of the neurotransmitter GABA to induce sleep—they can differ in their duration of action and potential side effects [5]. Benzodiazepines, such as alprazolam and lorazepam, are another class of drugs used for insomnia but have a different chemical structure and may carry different risks [6].
What Are the Potential Side Effects of Zolpidem?
Common side effects of zolpidem can include drowsiness, dizziness, and diarrhea [3]. More serious side effects, though less common, may involve complex sleep behaviors such as sleepwalking, sleep-driving, or engaging in other activities while not fully awake [3].
Can Zolpidem Be Addictive?
Like other sedative-hypnotic medications, zolpidem has the potential for dependence and abuse [3][7]. It is important to use zolpidem exactly as prescribed and for the shortest duration necessary to avoid withdrawal symptoms or the development of tolerance [3][7].
What Are the Regulatory Status and Availability of Zolpidem?
Zolpidem is a prescription medication [3]. In the United States, it is classified as a Schedule IV controlled substance due to its potential for abuse and dependence [7]. Availability of both brand-name and generic versions ensures wider access for patients who require treatment for insomnia.
Sources:
[1] https://www.drugs.com/zolpidem.html
[2] https://www.medicines.org.uk/emc/product/7184/smpc
[3] https://www.nhs.uk/medicines/zolpidem/
[4] https://drugpatentwatch.com/
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251175/
[6] https://www.ncbi.nlm.nih.gov/books/NBK553080/
[7] https://www.dea.gov/drug-scheduling